Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intervention Using Vitamin D for Elevated Urinary ALbumin in Diabetes (IDEAL-2)

NCT03216564 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT03216564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03216564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intervention Using Vitamin D for Elevated Urinary ALbumin in Diabetes (IDEAL-2)
Lead sponsor
Hamad Medical Corporation
Phase
Phase 3
Overall status
Unknown status
Start date
May 10, 2017
Completion date
May 10, 2019
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathies